These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30738658)

  • 1. Discordance in Antenatal Corticosteroid Use and Resuscitation Following Extremely Preterm Birth.
    Rysavy MA; Bell EF; Iams JD; Carlo WA; Li L; Mercer BM; Hintz SR; Stoll BJ; Vohr BR; Shankaran S; Walsh MC; Brumbaugh JE; Colaizy TT; Das A; Higgins RD;
    J Pediatr; 2019 May; 208():156-162.e5. PubMed ID: 30738658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants.
    Smith PB; Ambalavanan N; Li L; Cotten CM; Laughon M; Walsh MC; Das A; Bell EF; Carlo WA; Stoll BJ; Shankaran S; Laptook AR; Higgins RD; Goldberg RN; ;
    Pediatrics; 2012 Jun; 129(6):e1508-16. PubMed ID: 22641761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study.
    Norberg H; Kowalski J; Maršál K; Norman M
    BJOG; 2017 Sep; 124(10):1567-1574. PubMed ID: 28294496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children.
    Gentle SJ; Carlo WA; Tan S; Gargano M; Ambalavanan N; Chawla S; Bell EF; Bann CM; Hintz SR; Heyne RJ; Tita A; Higgins RD;
    Obstet Gynecol; 2020 Jun; 135(6):1377-1386. PubMed ID: 32459430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.
    Carlo WA; McDonald SA; Fanaroff AA; Vohr BR; Stoll BJ; Ehrenkranz RA; Andrews WW; Wallace D; Das A; Bell EF; Walsh MC; Laptook AR; Shankaran S; Poindexter BB; Hale EC; Newman NS; Davis AS; Schibler K; Kennedy KA; Sánchez PJ; Van Meurs KP; Goldberg RN; Watterberg KL; Faix RG; Frantz ID; Higgins RD;
    JAMA; 2011 Dec; 306(21):2348-58. PubMed ID: 22147379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of an Updated Neonatal Research Network Extremely Preterm Birth Outcome Model in the Vermont Oxford Network.
    Rysavy MA; Horbar JD; Bell EF; Li L; Greenberg LT; Tyson JE; Patel RM; Carlo WA; Younge NE; Green CE; Edwards EM; Hintz SR; Walsh MC; Buzas JS; Das A; Higgins RD;
    JAMA Pediatr; 2020 May; 174(5):e196294. PubMed ID: 32119065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Between-hospital variation in treatment and outcomes in extremely preterm infants.
    Rysavy MA; Li L; Bell EF; Das A; Hintz SR; Stoll BJ; Vohr BR; Carlo WA; Shankaran S; Walsh MC; Tyson JE; Cotten CM; Smith PB; Murray JC; Colaizy TT; Brumbaugh JE; Higgins RD;
    N Engl J Med; 2015 May; 372(19):1801-11. PubMed ID: 25946279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the Antenatal Late Preterm Steroids trial on the administration of antenatal corticosteroids.
    Kearsey EOR; Been JV; Souter VL; Stock SJ
    Am J Obstet Gynecol; 2022 Aug; 227(2):280.e1-280.e15. PubMed ID: 35341727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Antenatal Corticosteroid Exposure and Infant Survival at 22 and 23 Weeks.
    Rossi RM; DeFranco EA; Hall ES
    Am J Perinatol; 2023 Dec; 40(16):1789-1797. PubMed ID: 34839472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Antenatal Corticosteroids With Mortality, Morbidity, and Neurodevelopmental Outcomes in Extremely Preterm Multiple Gestation Infants.
    Boghossian NS; McDonald SA; Bell EF; Carlo WA; Brumbaugh JE; Stoll BJ; Laptook AR; Shankaran S; Walsh MC; Das A; Higgins RD;
    JAMA Pediatr; 2016 Jun; 170(6):593-601. PubMed ID: 27088897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive care for extreme prematurity--moving beyond gestational age.
    Tyson JE; Parikh NA; Langer J; Green C; Higgins RD;
    N Engl J Med; 2008 Apr; 358(16):1672-81. PubMed ID: 18420500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now?
    Kamath-Rayne BD; Rozance PJ; Goldenberg RL; Jobe AH
    Am J Obstet Gynecol; 2016 Oct; 215(4):423-30. PubMed ID: 27342043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of antenatal corticosteroids by year of birth among preterm infants in Canada during 2003-2017: a population-based cohort study.
    Melamed N; Murphy K; Barrett J; Asztalos E; McDonald SD; Yoon EW; Shah PS;
    BJOG; 2021 Feb; 128(3):521-531. PubMed ID: 32936996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years: multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5).
    Asztalos E; Willan A; Murphy K; Matthews S; Ohlsson A; Saigal S; Armson A; Kelly E; Delisle MF; Gafni A; Lee S; Sananes R; Rovet J; Guselle P; Amankwah K;
    BMC Pregnancy Childbirth; 2014 Aug; 14():272. PubMed ID: 25123162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/Ethnic Disparities Among Extremely Preterm Infants in the United States From 2002 to 2016.
    Travers CP; Carlo WA; McDonald SA; Das A; Ambalavanan N; Bell EF; Sánchez PJ; Stoll BJ; Wyckoff MH; Laptook AR; Van Meurs KP; Goldberg RN; D'Angio CT; Shankaran S; DeMauro SB; Walsh MC; Peralta-Carcelen M; Collins MV; Ball MB; Hale EC; Newman NS; Profit J; Gould JB; Lorch SA; Bann CM; Bidegain M; Higgins RD;
    JAMA Netw Open; 2020 Jun; 3(6):e206757. PubMed ID: 32520359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of maternal characteristics on the moderately premature infant: an antenatal maternal transport clinical prediction rule.
    Dukhovny D; Dukhovny S; Pursley DM; Escobar GJ; McCormick MC; Mao WY; Zupancic JA
    J Perinatol; 2012 Jul; 32(7):532-8. PubMed ID: 22076416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between antenatal corticosteroid exposure and neurodevelopment in infants.
    Tao S; Du J; Chi X; Zhu Y; Wang X; Meng Q; Ling X; Diao F; Song C; Jiang Y; Lv H; Lu Q; Qin R; Huang L; Xu X; Liu C; Ding Y; Jiang T; Ma H; Xia Y; Liu J; Lin Y; Jin G; Hu Z;
    Am J Obstet Gynecol; 2022 Nov; 227(5):759.e1-759.e15. PubMed ID: 35667419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proactive neonatal treatment at 22 weeks of gestation: a systematic review and meta-analysis.
    Backes CH; Rivera BK; Pavlek L; Beer LJ; Ball MK; Zettler ET; Smith CV; Bridge JA; Bell EF; Frey HA
    Am J Obstet Gynecol; 2021 Feb; 224(2):158-174. PubMed ID: 32745459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study.
    Travers CP; Clark RH; Spitzer AR; Das A; Garite TJ; Carlo WA
    BMJ; 2017 Mar; 356():j1039. PubMed ID: 28351838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.